Spinal Devices and Biologics Market in the US 2011-2015 New Report
Analysts forecast the Spinal Devices and Biologics market in the US to grow at a CAGR of 1.2 percent over the period 2011-2015. One of the key factors contributing to this market growth is the development of better and longer-lasting implants. The Spinal Devices and Biologics market in the US has also been witnessing increasing popularity of minimally invasive surgery. However, the reduction in reimbursements for spinal procedures could pose a challenge to the growth of this market.